Cannabis Legalization Bill Reintroduced to the Senate 

A bill to legalize cannabis federally has been reintroduced in Congress, led by Democratic Senators Cory Booker (NJ), Chuck Schumer (NY), and Ron Wyden (OR). The Cannabis Administration and Opportunity Act would completely remove cannabis from the Controlled Substances Act and establish a Center for Cannabis Products to regulate production, labeling, distribution, sales, and other manufacturing and retail elements of the cannabis industry. 

Booker, in a press release, said that, if passed, this legislation “would dismantle unjust, outdated, federal marijuana prohibitions, establish federal regulations to protect the public’s health and safety, and expunge previous convictions for minor cannabis offenses.” 

The measure seeks to instructing the Food and Drug Administration to establish labeling standards for cannabis products, including potency, doses, servings, place of manufacture, and directions for use; establish programs and funding to prevent youth cannabis use; and increase funding for comprehensive opioid, stimulant, and substance use disorder treatment. 

The overcriminalization has caused far too much death, and has disproportionately affected communities of color. The Cannabis Administration and Opportunity Act would be necessary and correct historic wrongs, while also investing in safety and research. It will protect workers rights and provide banking access for the industry. The movement is budding, and I won’t stop until restorative justice is achieved. The American people overwhelmingly support the federal legalization of cannabis – it’s long past time the government caught up.” — Schumer in a press release 

The proposal would retain federal prohibitions on trafficking cannabis in violation of state law and establish a grant program to help departments combat illicit cannabis; require the Department of Transportation to create standards for cannabis-impaired driving; direct the National Highway Traffic Safety Administration to collect data on cannabis-impaired driving, create educational materials on best practices, and carry out public service ad campaigns; and incentivize states to adopt cannabis open-container prohibitions. 

Wyden, in a press release said that he believes the “only thing reefer madness is” the continuing federal prohibition of marijuana. 

He said that his legislation was the most comprehensive plan to eliminate federal cannabis prohibition, while keeping the public’s health and safety at its forefront. “The federal governments needs to catch up with modern times and our bill would be the best way to achieve that.” 

Additionally, the bill would transfer federal jurisdiction over cannabis to the Alcohol and Tobacco Tax and Trade Bureau; eliminate the tax code’s restriction on cannabis businesses claiming deductions for business expenses and implementing an excise tax on cannabis products; establish market competition rules meant to protect independent producers, wholesalers, and retailers, and prevent anti-competitive behavior. 

The measure also contains provisions to encourage cannabis research, prioritize restorative and economic justice for communities and individuals most harmed by federal prohibition and the War on Drugs, and language to strengthen workers’ rights, including removing unnecessary federal employee pre-employment and random drug testing for cannabis. 

The proposal is co-sponsored by Senators Michael Bennet (D-CO), John Fetterman (D-PA), Kirsten Gillibrand (D-NY), John Hickenlooper (D-CO), Ben Ray Luján (D-NM), Alex Padilla (D-CA), Gary Peters (D-MI), Tina Smith (D-MN), Raphael Warnock (D-GA), Ed Markey (D-MA), Jeff Merkley (D-OR), Patty Murray (D-WA), Elizabeth Warren (D-MA), and Peter Welch (D-VT). 

MEDACAN24Daily insights from 2014 Cannabis Business Journal is the premier digital publication for industry professionals.. Join our community of more than 40,000 Ganjapreneurs by subscribing to our newsletter.

Cannabis Law Resources for Poland

Discover essential legal information about the cultivation of cannabis, its sale, and regulations governing medical products in Poland. These guides will help you understand the legal requirements, such as certification and permissions.

• 
  Polish News Registration and Interests of Cannabis Businesses
  
• 
  Permissions for Cannabis Sales in Poland
  
• 
  Authorization for Importing or Manufacturing Medical Products
  
• 
  Permission for Manufacturing or Importing Medical Products
  
• 
  Certificate of Good Manufacturing Practices (GMP)
  
• 
  Registration of Medical Products in Poland